Menu
Not yet recruiting NCT07630415

EARLY DIAGNOSIS OF SEPTIC DIC

Observational Disseminated Intravascular Coagulation (DIC) Reanimation Septic Shock

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Disseminated Intravascular Coagulation (DIC), Reanimation, Septic Shock. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

OPTIMIZATION AND CLINICAL VALIDATION OF AN INNOVATIVE TEST FOR THE EARLY DIAGNOSIS OF SEPTIC DIC VIA AN AUTOMATION INTEGRATING ARTIFICIAL INTELLIGENCE

Overview

Disseminated Intravascular Coagulation is a severe complication of septic shock, associated with high mortality, whose diagnosis relies on complex scores that are rarely used in practice. Preliminary studies have shown that increased neutrophil fluorescence is associated with Disseminated Intravascular Coagulation and could reflect NETosis, a key mechanism of immunothrombosis. This study aims to validate neutrophil fluorescence measured on the SthemA 801 analyzer, alone or integrated into an artificial intelligence model, as an early, reliable, and routinely usable biomarker for the diagnosis of septic Disseminated Intravascular Coagulation.

Primary outcome measures

  • Early diagnosis of disseminated intravascular coagulation in patients with septic shock hospitalized in medical intensive care using the neutrophil fluorescence ratio or an AI model based on complete blood count results [Time frame: From admission to intensive care until day 2 after admission]

Eligibility criteria

Inclusion criteria

  • Male or female ≥ 18 years old
  • Patient admitted to intensive care for septic shock
  • Patient affiliated with a social security scheme or having rights
  • No objection from the patient or a relative in case the patient is not able to express consent, or inclusion under emergency procedure in case the patient is not able to express their opinion and no relative of the patient is reachable.

Exclusion criteria

  • Moribund patient on the day of inclusion
  • Child-Pugh C cirrhosis
  • Neutropenia (<500 mm3)
  • Patient under legal protection
  • Patient under guardianship or curatorship
  • Pregnancy/ Breastfeeding

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

France · 1 center
  • The University Hospitals of Strasbourg, Intensive Care Medicine Department - New Civil Hos — Strasbourg

Identifiers

NCT: NCT07630415 · RC26_0023 · CE-2026-38

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗